The Future of Psychedelic Medicine

Our Story

Find out what inspires us to support mental health disorders.

Our Mission

Supporting innovative therapies to help humans thrive.

Our Team

Multi-Disciplinary Collaboration
creating positive experiences and outcomes.


Using a foundation of evidence-informed research, we want to empower people to achieve their potential and thrive.



Psychedelic medicine is the frontier of mental health and wellness

Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.

350 Million

People globally are affected by a form of depression.

1 Trillion

Dollars lost annually in global workforce productivity due to depression and anxiety.


Formulas standardized across clinical studies of psychedelic compounds.

Havn Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.

Press Releases

Havn Life Sciences signs agreement to supply psychedelic compounds for use in research and development to Revive Therapeutics

Havn Life will export naturally derived psilocybin to the United States, for use in IND-enabling studies and future clinical trials under FDA guidelines Vancouver, BC …

Read More →
Press Releases

Havn Life Sciences announces appointment of Dennis Staudt to the Board of Directors & Senior Management Reorganization

Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FSE : 5NP) (the “Company” or “Havn Life”),  is pleased to announce that Mr. Dennis …

Read More →
Press Releases

Havn Life applies for licence to produce and sell psilocybin

The Controlled Drugs and Substances Dealer’s Licence will allow Havn Life to supply naturally-derived psilocybin globally to universities, clinical researchers and companies Vancouver, BC – …

Read More →
Scroll to Top